Download PDF
Zeitschrift für Phytotherapie 2022; 43(06): 243-249
DOI: 10.1055/a-1924-9460
Forschung

Kurkuma- und Curcuminoid-Behandlung bei Gonarthrose

Systematischer Überblick klinischer StudienergebnisseTurmeric and Curcuminoid Treatment for Knee Osteoarthritis. A Systematic Overview of Clinical Trial Results
Miriam Bittel
1   Klinik für Integrative Medizin und Naturheilkunde, Sozialstiftung Bamberg, Klinikum am Bruderwald, Bamberg
2   Stiftungslehrstuhl für Innere und Integrative Medizin, Universität Duisburg-Essen, Klinikum am Bruderwald, Bamberg
,
Petra Klose
3   Department für Innere und Integrative Medizin, Kliniken Essen-Mitte, Medizinische Fakultät, Universität Duisburg-Essen, Essen
,
Jost Langhorst
1   Klinik für Integrative Medizin und Naturheilkunde, Sozialstiftung Bamberg, Klinikum am Bruderwald, Bamberg
2   Stiftungslehrstuhl für Innere und Integrative Medizin, Universität Duisburg-Essen, Klinikum am Bruderwald, Bamberg
› Author Affiliations
› Further Information
    Permissions and Reprints

Zusammenfassung

Hintergrund Die Kurkumawurzel (Curcuma longa L.) wird traditionell in der ayurvedischen, indischen und chinesischen Medizin verwendet. Aufgrund ihrer entzündungshemmenden Eigenschaften gelten Curcuminoide, insbesondere Curcumin, als die wichtigsten Wirkstoffe der Kurkumawurzel und stehen im Mittelpunkt der Forschung zur Behandlung von Kniearthrose (medizinisch als Gonarthrose bezeichnet).

Methodik Um einen systematischen Überblick über den aktuellen Stand der Evidenz in klinischen Studien zur Wirksamkeit und Sicherheit der Kurkuma- und Curcuminoid-Behandlung bei Kniearthrose zu erhalten, wurde eine systematische Literaturrecherche in mehreren Datenbanken und eine Evidenzbewertung nach den AWMF-Leitlinien durchgeführt.

Ergebnisse Neun systematische Übersichtsarbeiten mit Meta-Analyse im Suchzeitraum 2012–2021 auf der Basis von insgesamt 16 randomisiert kontrollierten Studien (RCTs) bewerten die orale Mono- und Komplementärtherapie mit Kurkuma und Curcuminoiden bei Kniearthrose. Curcuminoid-haltige Präparate wurden einvernehmlich als sichere und klinisch wirksame Therapieoption zur Verbesserung von Schmerz und Funktion bei Kniearthrose im Vergleich zu Placebo (11 RCTs, n=850) oder ergänzend zur Schmerztherapie mit nicht steroidalen Antirheumatika (NSAR) (5 RCTs, n=747) bewertet. Es sind jedoch qualitativ hochwertige, groß angelegte RCTs erforderlich, um die therapeutische Wirksamkeit und Sicherheit für eine Langzeitbehandlung zu bestätigen. Zudem sind aktuell Kurkumaextrakte in Deutschland nicht als Arzneimittel erhältlich.

Schlussfolgerung In Anbetracht der begrenzten und hohen Nebenwirkungsraten der derzeitigen Schmerzbehandlungsoptionen kann eine orale Phytotherapie auf Kurkumabasis für die symptomatische Behandlung von Kniearthrose und als Ergänzung zur Schmerztherapie empfohlen werden.

Abstract

Background The turmeric rhizome (Curcuma longa L.) is traditionally used in Ayurvedic, Indian and Chinese medicine. Due to their anti-inflammatory properties, curcuminoids, especially curcumin, are considered as most important active ingredients of the turmeric root and are in the focus of research for the treatment of knee osteoarthritis (gonarthrosis).

Methods To provide a systematic overview of the current level of evidence in clinical trials about efficacy and safety of turmeric and curcuminoid treatment in knee osteoarthritis, a systematic literature search in several databases and evidence evaluation according to AWMF guidelines was performed.

Results Nine systematic reviews with meta-analysis within the period from 2012 to 2021 based on a total of 16 RCTs evaluate oral mono- and complementary turmeric and curcuminoid therapy in knee osteoarthritis. Curcuminoid-containing preparations were evaluated as a safe and clinically effective therapeutic option for improving pain and function in knee osteoarthritis compared to placebo (11 RCTs, n=850) or complementary to pain therapy with non-steroidal anti-inflammatory drugs (NSAIDs) (5 RCTs, n=747). However, high-quality large-scale RCTs are needed to confirm the therapeutic efficacy and safety for long-term treatment and until now turmeric extracts are not available as medicinal products in the EU.

Conclusion Considering the limited and high side effect rates of current pain treatment options, oral turmeric-based herbal therapy can be recommended in the symptomatic treatment of knee osteoarthritis and adjunction to pain therapy.

Schlüsselwörter

Gonarthrose - Osteoarthritis - Knie - Kniearthrose - Kurkuma - Curcumin - Phytotherapie - Leitlinien - Übersichtsarbeit

Key words

knee osteoarthritis - turmeric - curcuminoid - curcumin - phytotherapy - herbal medicine - guidelines - systematic review


Publication History

Article published online:
28 November 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Peng Y, Ao M, Dong B. et al. Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures. Drug Des Devel Ther 2021; 15: 4503-4525
    CrossrefPubMedGoogle Scholar
  • 2 Esatbeyoglu T, Huebbe P, Ernst IM. et al. Curcumin – vom Molekül zur biologischen Wirkung. Angewandte Chemie 2012; 124: 5402-5427
    CrossrefPubMedGoogle Scholar
  • 3 Tabrizi R, Vakili S, Akbari M. et al. The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2019; 33: 253-262
    CrossrefPubMedGoogle Scholar
  • 4 Wang Z, Singh A, Jones G. et al. Efficacy and safety of turmeric extracts for the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomised controlled trials. Curr Rheumatol Rep 2021; 23: 11
    CrossrefPubMedGoogle Scholar
  • 5 Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-art management of knee osteoarthritis. World J Clin Cases 2015; 3: 89-101
    CrossrefPubMedGoogle Scholar
  • 6 Stewart C. Incidence of osteoarthritis in Europe in 2019, by joint and gender: statista; 2021 [updated 02.09.2021]. Im Internet: https://www.statista.com/statistics/1256140/osteoarthritis-incidence-in-europe-by-joint/
    PubMed
  • 7 Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003; 81: 646-656
    PubMedGoogle Scholar
  • 8 Murray CJ, Vos T, Lozano R. et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-2223
    CrossrefPubMedGoogle Scholar
  • 9 Bruyère O, Honvo G, Veronese N. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum 2019; 49: 337-350
    CrossrefPubMedGoogle Scholar
  • 10 Pinsornsak P, Niempoog S. The efficacy of Curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai 2012; 95: S51-S58
    PubMedGoogle Scholar
  • 11 Bannuru RR, Osani MC, Al-Eid F, Wang C. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Semin Arthritis Rheum 2018; 48: 416-429
    CrossrefPubMedGoogle Scholar
  • 12 Dai W, Yan W, Leng X. et al. Effectiveness of Curcuma longa extract versus placebo for the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2021; 35: 5921-5935
    CrossrefPubMedGoogle Scholar
  • 13 Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta-analysis of randomized clinical trials. J Med Food 2016; 19: 717-729
    CrossrefPubMedGoogle Scholar
  • 14 Gomes TPO, Souza JIN, Somerlate LC. et al. Miconia albicans and Curcuma longa herbal medicines positively modulate joint pain, function and inflammation in patients with osteoarthritis: a clinical study. Inflammopharmacology 2021; 29: 377-391
    CrossrefPubMedGoogle Scholar
  • 15 Heidari-Beni M, Moravejolahkami AR, Gorgian P. et al. Herbal formulation “turmeric extract, black pepper, and ginger” versus Naproxen for chronic knee osteoarthritis: A randomized, double-blind, controlled clinical trial. Phytother Res 2020; 34: 2067-2073
    CrossrefPubMedGoogle Scholar
  • 16 Hsiao AF, Lien YC, Tzeng IS. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis. Complement Ther Med 2021; 63: 102775
    CrossrefPubMedGoogle Scholar
  • 17 Jamali N, Adib-Hajbaghery M, Soleimani A. The effect of curcumin ointment on knee pain in older adults with osteoarthritis: a randomized placebo trial. BMC Complement Med Ther 2020; 20: 305
    CrossrefPubMedGoogle Scholar
  • 18 Khanna A, Das SS, Smina TP. et al. Curcumagalactomannoside/glucosamine combination improved joint health among osteoarthritic subjects as compared to chondroitin sulfate/glucosamine: double-blinded, randomized controlled study. J Altern Complement Med 2020; 26: 945-955
    CrossrefPubMedGoogle Scholar
  • 19 Lopresti AL, Smith SJ, Jackson-Michel S, Fairchild T. An investigation into the effects of a curcumin extract (Curcugen(®)) on osteoarthritis pain of the knee: A randomised, double-blind, placebo-controlled study. Nutrients 2021; 14: 41
    CrossrefPubMedGoogle Scholar
  • 20 Onakpoya IJ, Spencer EA, Perera R, Heneghan CJ. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. Int J Rheum Dis 2017; 20: 420-433
    CrossrefPubMedGoogle Scholar
  • 21 Paultre K, Cade W, Hernandez D. et al. Therapeutic effects of turmeric or curcumin extract on pain and function for individuals with knee osteoarthritis: a systematic review. BMJ Open Sport Exerc Med 2021; 7: e000935
    CrossrefPubMedGoogle Scholar
  • 22 Rahimnia AR, Panahi Y, Alishiri G. et al. Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: findings from a randomized double-blind placebo-controlled trial. Drug Res (Stuttg) 2015; 65: 521-525
    PubMedGoogle Scholar
  • 23 Rao PS, Ramanjaneyulu YS, Prisk VR, Schurgers LJ. A combination of Tamarindus indica seeds and Curcuma longa rhizome extracts improves knee joint function and alleviates pain in non-arthritic adults following physical activity. Int J Med Sci 2019; 16: 845-853
    CrossrefPubMedGoogle Scholar
  • 24 Ross SM. Turmeric (Curcuma longa): effects of Curcuma longa extracts compared with ibuprofen for reduction of pain and functional improvement in patients with knee osteoarthritis. Holist Nurs Pract 2016; 30: 183-186
    CrossrefPubMedGoogle Scholar
  • 25 Shep D, Khanwelkar C, Gade P, Karad S. Efficacy and safety of combination of curcuminoid complex and diclofenac versus diclofenac in knee osteoarthritis: A randomized trial. Medicine (Baltimore) 2020; 99: e19723
    CrossrefPubMedGoogle Scholar
  • 26 Singhal S, Hasan N, Nirmal K. et al. Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol. Trials 2021; 22: 105
    CrossrefPubMedGoogle Scholar
  • 27 Sterzi S, Giordani L, Morrone M. et al. The efficacy and safety of a combination of glucosamine hydrochloride, chondroitin sulfate and bio-curcumin with exercise in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled study. Eur J Phys Rehabil Med 2016; 52: 321-330
    PubMedGoogle Scholar
  • 28 Thomas JV, Smina TP, Khanna A. et al. Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial. Phytother Res 2021; 35: 1443-1455
    CrossrefPubMedGoogle Scholar
  • 29 Wu J, Lv M, Zhou Y. Efficacy and side effect of curcumin for the treatment of osteoarthritis: A meta-analysis of randomized controlled trials. Pak J Pharm Sci 2019; 32: 43-51
    PubMedGoogle Scholar
  • 30 Zeng L, Yu G, Hao W. et al. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis. Biosci Rep 2021; 41: BSR20210817 DOI: 10.1042/BSR20210817.
    CrossrefPubMedGoogle Scholar
  • 31 Haroyan A, Mukuchyan V, Mkrtchyan N. et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med 2018; 18: 7
    CrossrefPubMedGoogle Scholar
  • 32 Atabaki M, Shariati-Sarabi Z, Tavakkol-Afshari J, Mohammadi M. Significant immunomodulatory properties of curcumin in patients with osteoarthritis; a successful clinical trial in Iran. Int Immunopharmacol 2020; 85: 106607
    CrossrefPubMedGoogle Scholar
  • 33 Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 2012; 26: 1719-1725
    CrossrefPubMedGoogle Scholar
  • 34 Hashemzadeh K, Davoudian N, Jaafari MR, Mirfeizi Z. The effect of nanocurcumin in improvement of knee osteoarthritis: A randomized clinical trial. Curr Rheumatol Rev 2020; 16: 158-164
    CrossrefPubMedGoogle Scholar
  • 35 Henrotin Y, Malaise M, Wittoek R. et al. Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study. Arthritis Res Ther 2019; 21: 179
    CrossrefPubMedGoogle Scholar
  • 36 Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W. et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging 2014; 9: 451-458
    CrossrefPubMedGoogle Scholar
  • 37 Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P. et al. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J Altern Complement Med 2009; 15: 891-897
    CrossrefPubMedGoogle Scholar
  • 38 Madhu K, Chanda K, Saji M. Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial. Inflammopharmacology 2013; 21: 129-136
    CrossrefPubMedGoogle Scholar
  • 39 Moharamzad Y, Panahi Y, Rahimnia A, Beiraghdar F. Clinical efficacy of curcumin in knee osteoarthritis: a double-blind randomized clinical trial. Baqiyatallah Medical Sciences University. 2011
    PubMedGoogle Scholar
  • 40 Nakagawa Y, Mukai S, Yamada S. et al. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthopaedic Sci 2014; 19: 933-939
    CrossrefPubMedGoogle Scholar
  • 41 Panahi Y, Rahimnia AR, Sharafi M. et al. Curcuminoid treatment for knee osteoarthritis: A randomized double-blind placebo-controlled trial. Phytother Res 2014; 28: 1625-1631
    CrossrefPubMedGoogle Scholar
  • 42 Panda SK, Nirvanashetty S, Parachur VA. et al. A randomized, double blind, placebo controlled, parallel-group study to evaluate the safety and efficacy of Curene® versus placebo in reducing symptoms of knee OA. Biomed Res Int 2018; 2018: 5291945
    CrossrefPubMedGoogle Scholar
  • 43 Srivastava S, Saksena AK, Khattri S. et al. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology 2016; 24: 377-388
    CrossrefPubMedGoogle Scholar
  • 44 Wang Z, Jones G, Winzenberg T. et al. Effectiveness of Curcuma longa extract for the treatment of symptoms and effusion – synovitis of knee osteoarthritis: A randomized trial. Ann Intern Med 2020; 173: 861-869
    CrossrefPubMedGoogle Scholar
  • 45 Shep D, Khanwelkar C, Gade P, Karad S. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study. Trials 2019; 20: 1-11
    CrossrefPubMedGoogle Scholar
  • 46 Appelboom T, Maes N, Albert A. A new curcuma extract (flexofytol®) in osteoarthritis: results from a Belgian real-life experience. Open Rheumatol J 2014; 8: 77-81
    CrossrefPubMedGoogle Scholar
  • 47 Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond) 2013; 13: 7-12
    CrossrefPubMedGoogle Scholar
  • 48 Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytother Res 2018; 32: 985-995
    CrossrefPubMedGoogle Scholar
  • 49 Hatamipour M, Sahebkar A, Alavizadeh SH. et al. Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids. Iran J Basic Med Sci 2019; 22: 282-289
    PubMedGoogle Scholar
  • 50 Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 2003; 9: 161-168
    CrossrefPubMedGoogle Scholar
  • 51 European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizoma. 25.09.2018. EMA/HMPC/329755/2017
    PubMed
  • 52 EU Register – Nutrition and Health claims. Im Internet: http://ec.europa.eu/food/safety/labelling_nutrition/claims/register/public/?event=register.home
    PubMed
  • 53 EFSA Panel on Dietetic Products N, Allergies; Turck D, Bresson JL, Burlingame B et al. Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2017; 15: e04774
    PubMedGoogle Scholar
  • 54 European Medicines Agency. Curcumae longae rhizoma. Im Internet: https://www.ema.europa.eu/en/medicines/herbal/curcumae-longae-rhizoma
    PubMed
  • 55 EFSA Panel on Nutrition, Novel Foods and Food Allergens. Safety of tetrahydrocurcuminoids from turmeric (Curcuma longa L.) as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal 2021; 19: e06936 DOI: 10.2903/j.efsa.2021.6936.
    CrossrefPubMedGoogle Scholar
  • 56 Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Bundesinstitut für Arzneimittel und Medizinprodukte. Gemeinsame Expertenkommission zur Einstufung von Stoffen – Stellungnahme zur Einstufung von Produkten, die Curcumin mit verbesserter Bioverfügbarkeit enthalten (02/2020). Im Internet: https://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Zulassung/ZulRelThemen/abgrenzung/Expertenkommission/stellungnahmen/2020-02.pdf?__blob=publicationFile
    PubMed